InPheno Company

InPheno provides custom antiviral testing services from screening and lead optimisation support, to candidate profiling and mode of action. They strive to be the one-stop solution for your needs in research and profiling of antiviral drug candidates in the field of HIV, hepatitis, and respiratory viruses. InPheno’s laboratories opened in Basel, Switzerland, in 2001 as a spin-off from the Institute of Medical Microbiology, University of Basel, Switzerland. InPheno’s founders and operating team consists of specialists in the fields of virology and oncology with long-term experience in the pharmaceutical industry. Their scientists combine a broad expertise in molecular and cellular assay technology as well as in the development of modern therapeutics.